Embracing Diversity & Inclusion
-
How Do Underserved Communities Prefer To Learn About Clinical Research?
5/5/2020
It is important to look at the big picture and better understand core participation motivators and barriers from the underrepresented patient’s perspective in order to better enable access to and increase their participation in clinical trials.
-
Bridging The Chasm Between The Haves And The Have-Nots In Cancer Trials
4/9/2020
Clinical trials are the most important and reliable means available to provide scientific evidence for developing therapies and effective care management for patients. It is therefore essential to achieve diverse participation in clinical trials in order to ensure medical advancements — whether for testing or treating COVID-19 or for cancer therapeutics — are applicable to all populations.
-
4 Questions AbbVie Asked To Create More Diverse Clinical Trials
1/17/2020
Over the five years I have been at AbbVie, the idea of diversity and inclusivity in healthcare was especially relevant to our clinical trials in uterine fibroids. We successfully centered patients in our program by understanding their needs, concerns, and desires, which enabled us to recruit and retain women representative of the patient landscape in this disease state. How? We asked ourselves four important questions.